Posted inBusiness

San Diego’s Illumina to Pay $7.1 Billion for Developer of Cancer Blood Test

San Diego gene-sequencing powerhouse Illumina announced Monday it will pay $7.1 billion for a startup company developing a blood test that promises early detection of cancer. GRAIL, which Illumina founded four years ago as a standalone company, is developing a multi-cancer screening test that is expected to be available for clinical use next year. “Over […]